Oxana Ovakimyan MD
@droxana.bsky.social
Interventional Cardiologist in NJ
Reposted by Oxana Ovakimyan MD
Enough is enough:
RETREAT-FRAIL www.nejm.org/doi/full/10....
OPTIMISE
www.thelancet.com/journals/lan...
DANTON
academic.oup.com/ageing/artic...
No mortality benefit (and potentially harm) from antihypertensive deprescription among frail older adults. Meta-analyze that!
RETREAT-FRAIL www.nejm.org/doi/full/10....
OPTIMISE
www.thelancet.com/journals/lan...
DANTON
academic.oup.com/ageing/artic...
No mortality benefit (and potentially harm) from antihypertensive deprescription among frail older adults. Meta-analyze that!
Reduction of Antihypertensive Treatment in Nursing Home Residents | NEJM
Among older adults with frailty, evidence on the benefits and risks of discontinuing
antihypertensive drugs is limited. In a multicenter, randomized, controlled trial
conducted in France, we assign...
www.nejm.org
October 1, 2025 at 9:45 AM
Enough is enough:
RETREAT-FRAIL www.nejm.org/doi/full/10....
OPTIMISE
www.thelancet.com/journals/lan...
DANTON
academic.oup.com/ageing/artic...
No mortality benefit (and potentially harm) from antihypertensive deprescription among frail older adults. Meta-analyze that!
RETREAT-FRAIL www.nejm.org/doi/full/10....
OPTIMISE
www.thelancet.com/journals/lan...
DANTON
academic.oup.com/ageing/artic...
No mortality benefit (and potentially harm) from antihypertensive deprescription among frail older adults. Meta-analyze that!
Reposted by Oxana Ovakimyan MD
💡Takeaways:
✅PAD walking impairment is largely driven by microvascular dysfunction.
✅Improvements in microvascular function, not conduit artery revascularization, predict walking improvement.
✅New therapies should target the microvasculature as a key mechanism of recovery.
✅PAD walking impairment is largely driven by microvascular dysfunction.
✅Improvements in microvascular function, not conduit artery revascularization, predict walking improvement.
✅New therapies should target the microvasculature as a key mechanism of recovery.
September 5, 2025 at 1:53 AM
💡Takeaways:
✅PAD walking impairment is largely driven by microvascular dysfunction.
✅Improvements in microvascular function, not conduit artery revascularization, predict walking improvement.
✅New therapies should target the microvasculature as a key mechanism of recovery.
✅PAD walking impairment is largely driven by microvascular dysfunction.
✅Improvements in microvascular function, not conduit artery revascularization, predict walking improvement.
✅New therapies should target the microvasculature as a key mechanism of recovery.
Reposted by Oxana Ovakimyan MD
Finally some good evidence for whether DOACs can be effective in treatment of left ventricular thrombus. Is this generalisable to all DOACs? #cardiosky #cccsky www.jacc.org/doi/10.1016/...
Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT
www.jacc.org
September 5, 2025 at 6:42 PM
Finally some good evidence for whether DOACs can be effective in treatment of left ventricular thrombus. Is this generalisable to all DOACs? #cardiosky #cccsky www.jacc.org/doi/10.1016/...
Reposted by Oxana Ovakimyan MD
#WeekendReads from the #AdvanceAccess
Renal Denervation: a State of the Art Review
🔗 academic.oup.com/ajh/advance-... 🔓
Renal Denervation: a State of the Art Review
🔗 academic.oup.com/ajh/advance-... 🔓
August 24, 2025 at 12:30 PM
#WeekendReads from the #AdvanceAccess
Renal Denervation: a State of the Art Review
🔗 academic.oup.com/ajh/advance-... 🔓
Renal Denervation: a State of the Art Review
🔗 academic.oup.com/ajh/advance-... 🔓
Reposted by Oxana Ovakimyan MD
Predicting Alzheimer's in people who are cognitively unimpaired in middle-age via blood tests
p-tau217 did well (best single biomarker), its ratio with Aβ42 had highest performance for detecting PET + amyloid
new publication today
www.thelancet.com/journals/ebi...
p-tau217 did well (best single biomarker), its ratio with Aβ42 had highest performance for detecting PET + amyloid
new publication today
www.thelancet.com/journals/ebi...
May 25, 2025 at 4:44 PM
Predicting Alzheimer's in people who are cognitively unimpaired in middle-age via blood tests
p-tau217 did well (best single biomarker), its ratio with Aβ42 had highest performance for detecting PET + amyloid
new publication today
www.thelancet.com/journals/ebi...
p-tau217 did well (best single biomarker), its ratio with Aβ42 had highest performance for detecting PET + amyloid
new publication today
www.thelancet.com/journals/ebi...
Reposted by Oxana Ovakimyan MD
Hating on “Big Pharma”? Cool, it’s a $1.6 trillion regulated industry. But hang on…the $6.3 trillion wellness industry sells you mushroom tea, dewormers, crash diets, and alkaline water—no regulations, no oversight. But hey, it’s ‘natural,’ right?
April 30, 2025 at 1:36 AM
Hating on “Big Pharma”? Cool, it’s a $1.6 trillion regulated industry. But hang on…the $6.3 trillion wellness industry sells you mushroom tea, dewormers, crash diets, and alkaline water—no regulations, no oversight. But hey, it’s ‘natural,’ right?
Reposted by Oxana Ovakimyan MD
New report shows that NIH grants fueled $95 billion in economic activity and 407,782 jobs in 2024.
That's not to mention the countless lives that biomedical research has saved.
Show me a better investment than that.
www.forbes.com/sites/michae...
That's not to mention the countless lives that biomedical research has saved.
Show me a better investment than that.
www.forbes.com/sites/michae...
NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report
National Institutes of Health grants generated almost $95 billion in economic activity nationwide in FY 2024 according to a new report by United for Medical Research.
www.forbes.com
March 12, 2025 at 8:47 PM
New report shows that NIH grants fueled $95 billion in economic activity and 407,782 jobs in 2024.
That's not to mention the countless lives that biomedical research has saved.
Show me a better investment than that.
www.forbes.com/sites/michae...
That's not to mention the countless lives that biomedical research has saved.
Show me a better investment than that.
www.forbes.com/sites/michae...
Reposted by Oxana Ovakimyan MD
This is what many cities in the U.S. looked like before the EPA.
Why the heck would anyone celebrate deregulating it?
Why the heck would anyone celebrate deregulating it?
March 13, 2025 at 12:37 AM
This is what many cities in the U.S. looked like before the EPA.
Why the heck would anyone celebrate deregulating it?
Why the heck would anyone celebrate deregulating it?
Reposted by Oxana Ovakimyan MD
2016, 2020, 2024—and they still don’t realize they’re on the menu…
February 24, 2025 at 2:52 AM
2016, 2020, 2024—and they still don’t realize they’re on the menu…
Reposted by Oxana Ovakimyan MD
NEW: Pregnancy became far more dangerous in Texas after the state banned abortion, according to ProPublica’s first-of-its-kind analysis, which found the sepsis rate for women hospitalized as they miscarried in the 2nd trimester shot up by more than 50%.
https://propub.li/43487Tj
https://propub.li/43487Tj
Texas Banned Abortion. Then Sepsis Rates Soared.
ProPublica’s first-of-its-kind analysis is the most detailed look yet into a rise in life-threatening complications for women experiencing pregnancy loss under Texas’ abortion ban.
propub.li
February 20, 2025 at 12:00 PM
NEW: Pregnancy became far more dangerous in Texas after the state banned abortion, according to ProPublica’s first-of-its-kind analysis, which found the sepsis rate for women hospitalized as they miscarried in the 2nd trimester shot up by more than 50%.
https://propub.li/43487Tj
https://propub.li/43487Tj
Reposted by Oxana Ovakimyan MD
Historians Politely Remind Nation To Check What's Happened In Past Before Making Any Big Decisions
theonion.com/historians-p...
theonion.com/historians-p...
February 18, 2025 at 5:17 PM
Historians Politely Remind Nation To Check What's Happened In Past Before Making Any Big Decisions
theonion.com/historians-p...
theonion.com/historians-p...
Reposted by Oxana Ovakimyan MD
Reposted by Oxana Ovakimyan MD
Its back! Ten current papers for the curious cardiologist, including BP targets in T2DM, spiro post MI, left atrial appendage occlusion, coronary sinus reducer for angina, device detected AF & tirzepatide in HFpEF #CardioSky
1/11
1/11
November 18, 2024 at 10:24 PM
Its back! Ten current papers for the curious cardiologist, including BP targets in T2DM, spiro post MI, left atrial appendage occlusion, coronary sinus reducer for angina, device detected AF & tirzepatide in HFpEF #CardioSky
1/11
1/11